The following patients were excluded from analysis: 57 patients with unknown MGMT status, 26 patients with IDH-mutant GBM, 12 patients with leptomeningeal disease or gliomatosis, 3 infratentorial GBM, and 1 K27M-mutant diffuse midline glioma. This evidence concerns the gene IDH2 and glioblastoma.